WebOn June 10, 2024, the Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck) for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous... WebApr 4, 2024 · What is carboplatin? Carboplatin belongs to a class of medications known as platinum-containing compounds. It works by stopping or slowing the growth of cancer …
Drug sequence with gemcitabine - Oncology Nurse Advisor
WebAlthough cisplatin has demonstrated its superiority over carboplatin for treatment of lung cancers and germ-cell tumors, the tolerance of carboplatin is better than that of cisplatin. This might be taken into account for patients treated with non-curative attempt. Further studies should compare both chemotherapy agents for quality of life. WebOct 14, 2024 · The key difference between carboplatin and cisplatin is that carboplatin shows less consistent survival advantages, whereas cisplatin shows more consistent survival advantages in meta … ceglarski komornik
Pharmaceutics Free Full-Text Pd (II) and Pt (II) Trinuclear ...
WebHowever, the toxicity of carboplatin was smaller than that of cisplatin in proximal tubular epithelial cells that had been preincubated with AGEs. Yokoo et al reported that … WebJul 10, 2024 · Chemotherapy consisted of pemetrexed plus either cisplatin or carboplatin for nonsquamous NSCLC and gemcitabine plus either cisplatin or carboplatin for squamous NSCLC. Nivolumab/ipilimumab treatment continued until disease progression, unacceptable toxicity, or for up to 24 months. WebOct 28, 2024 · Loriot Y, Massard C, Gross-Goupil M, et al. Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also … ceg lome zongo